BAM66436
Midostaurin
|
PKC 412 is a cell-permeable, reversible inhibitor of several serine/threonine and tyrosine kinases, including conventional PKC isoforms, Syk, Flk-1, Akt, PKA, c-Kit, C-Fgr, c-Src, FLT3, PDFRß, VEGFR1, and VEGFR2 with IC50 values ranging from 80-500 nM.
|
Quantity
Price
1 mg
110.00
|
|
C35H30N4O4
|
|
120685-11-2
|
|
99+%
|
|
MFCD10687105
|
|
BAM66436
PKC-412
|
PKC 412 is a cell-permeable, reversible inhibitor of several serine/threonine and tyrosine kinases, including conventional PKC isoforms, Syk, Flk-1, Akt, PKA, c-Kit, C-Fgr, c-Src, FLT3, PDFRß, VEGFR1, and VEGFR2 with IC50 values ranging from 80-500 nM.
|
Quantity
Price
1 mg
110.00
|
|
|
C35H30N4O4
|
|
120685-11-2
|
|
99+%
|
|
MFCD10687105
|
|
BAM66390
XL184
|
XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively.
|
Quantity
Price
10 mg
120.00
50 mg
470.00
200 mg
1470.00
|
|
C28H24FN3O5
|
|
849217-68-1
|
|
98+%
|
|
MFCD17010276
|
|
BAM66392
BAY 73-4506
|
Regorafenib (BAY 73-4506) is a multikinase inhibitor with IC50 of 17, 40 and 69 nM c-KIT, VEGFR2, B-Raf.
|
Quantity
Price
10 mg
120.00
50 mg
450.00
100 mg
750.00
200 mg
1200.00
|
|
C21H15ClF4N4O3
|
|
755037-03-7
|
|
98+%
|
|
MFCD16038047
|
|
BAM66390
Cabozantinib
|
XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively.
|
Quantity
Price
10 mg
120.00
50 mg
470.00
200 mg
1470.00
|
|
|
C28H24FN3O5
|
|
849217-68-1
|
|
98+%
|
|
MFCD17010276
|
|
|